{
  "docId": "019de071-fee7-744f-89ad-50de02e7ef2c",
  "docSlug": "b5a336d0fe4b7b554c90c4664e01c224",
  "documentTitle": "Comera | SPAC Presentation Deck | 33 slides",
  "authorId": "comera",
  "authorName": "Comera Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 33,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 9,
  "notes": "The slide combines a program summary table with a bar chart showing market growth projections.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-fee7-744f-89ad-50de02e7ef2c/23",
  "deckHref": "/decks/019de071-fee7-744f-89ad-50de02e7ef2c",
  "deckJsonHref": "/decks/019de071-fee7-744f-89ad-50de02e7ef2c.json",
  "deckAnchorHref": "/decks/019de071-fee7-744f-89ad-50de02e7ef2c#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.38,
        "x": 0.58,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Global IBD Market Revenue in billions (USD) from 2020 to 2028",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e5e264e-4f8b-4987-b7db-67906bddb053",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.04,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "First program focuses on formulating a SQ version of a widely-marketed, successful IV biologic therapy targeting Inflammatory Bowel Disease (IBD)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b339cc88-9cfa-4c4b-bb43-72f67432157b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.04,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Source: https://www.grandviewresearch.com/industry-analysis/inflammatory-bowel-disease-ibd-treatment-market; https://www.marketwatch.com/press-release/inflammatory-bowel-disease-ibd-treatment-market-analysis-share-trends-size-forecast-from-2020---2030-2021-11-01?tesla=y ; https://www.yahoo.com/now/global-inflammatory-bowel-disease-treatment-103800897.html; https://qualiketresearch.com/reports-details/Inflammatory-Bowel-Disease-Treatment-Market; Al-Horani et.,al., Nat Rev Drug Disc (21):2022; Peak sales potential reflects maximum estimated sales in a 12-month period following approval.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9651f1a-27b9-445f-82e4-34f610804a71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.04,
        "y": 0.29
      },
      "kind": "table",
      "text": "Program: SQ formulation of marketed IV mAb; Therapeutic Area: IBD (Ulcerative colitis and Crohn's disease); Development Status: Formulation development; Key Milestone: IND filing: Q1 2024; Competition: No SQ in US; Peak Sales Potential: $250M-$500M base case",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57365f6a-cb8d-47c4-ab4c-f86faa517e64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "CLS-001: Addressing Unmet Need in Large Market",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc8f32b2-7ce3-4d05-b460-6e6ef873d13d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Market Segmentation Pyramid",
      "slug": "market-segmentation-pyramid",
      "agent": null,
      "layer": "slide",
      "matchId": "d6deccf2-0e18-42df-9f71-d678b16b5d32",
      "evidence": "chart/bar-vertical: Global IBD Market Revenue in billions (USD) from 2020 to 2028",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}